(Q48254946)

10 February 2018

title

18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson's disease in various Hoehn & Yahr stages (English)

1 reference

10 February 2018

0 references

1 reference

Jian Wang

1

1 reference

10 February 2018

Cuan-Tao Zuo

2

1 reference

10 February 2018

Yu-Ping Jiang

3

1 reference

10 February 2018

Yi-Hui Guan

4

1 reference

10 February 2018

Zheng-Ping Chen

5

1 reference

10 February 2018

Jing-De Xiang

6

1 reference

10 February 2018

Li-Qin Yang

7

1 reference

10 February 2018

Zheng-Tong Ding

8

1 reference

10 February 2018

Jian-Jun Wu

9

1 reference

10 February 2018

Hui-Lin Su

10

1 reference

10 February 2018

publication date

1 February 2007

1 reference

10 February 2018

published in

Journal of Neurology

1 reference

10 February 2018

volume

254

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

185-190

1 reference

10 February 2018

Comparison of two pet radioligands for imaging extrastriatal dopamine transporters in human brain.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-0322-9

[11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: implications for the symptomatic threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-0322-9

PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-0322-9

[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-0322-9

The role of radiotracer imaging in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-0322-9

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

12 December 2020

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

1 reference

12 December 2020

1 reference

12 December 2020

How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson's disease?

1 reference

12 December 2020

Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease

1 reference

12 December 2020

Accurate three-dimensional registration of CT, PET, and/or MR images of the brain

1 reference

12 December 2020

Dosimetry of the dopamine transporter radioligand 18F-FPCIT in human subjects.

1 reference

12 December 2020

Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.

1 reference

12 December 2020

Imaging of dopamine transporters in humans with technetium-99m TRODAT-1

1 reference

12 December 2020

[18F]CFT [(18F)WIN 35,428], a radioligand to study the dopamine transporter with PET: characterization in human subjects

1 reference

12 December 2020

Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: a PET study.

1 reference

12 December 2020

Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.

1 reference

12 December 2020

Regulation of dopaminergic activity in early Parkinson's disease

1 reference

12 December 2020

Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.

1 reference

12 December 2020

Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson's disease

1 reference

12 December 2020

Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease

1 reference

12 December 2020

Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.

1 reference

12 December 2020

Dopamine transporter imaging with fluorine-18-FPCIT and PET.

1 reference

12 December 2020

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

1 reference

12 December 2020

The status of dopamine nerve terminals in Parkinson's disease and essential tremor: a PET study with the tracer [11-C]FE-CIT.

1 reference

12 December 2020

Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT.

1 reference

12 December 2020

Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.

1 reference

12 December 2020

Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism

1 reference

12 December 2020

[(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease

1 reference

12 December 2020

10.1007/S00415-006-0322-9

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018